Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba(R) Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC
(NASDAQ:SCLX), PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic […]